Serum phospholipase A2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shock
- PMID: 1740964
- DOI: 10.1016/0024-3205(92)90186-s
Serum phospholipase A2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shock
Abstract
Massive elevations of serum phospholipase A2 activity have been documented in patients with septic shock. Serum PLA2 activity correlated to the degree and duration of circulatory collapse, while purified native PLA2 reproduced hypotension in experimental animals. In a prospective study of patients with septic shock, we have determined the relationship of PLA2 enzyme activity to PLA2 immunoreactivity using radiolabelled E. coli phospholipid substrate and an ELISA specific for group II human nonpancreatic PLA2. In all patients, there was a clear concordance of the two assays. Maximal PLA2 concentration was increased a mean of 554-fold over normal levels. We found no evidence to support the presence of activating or inhibitory proteins. These data confirm that the observed increase in serum PLA2 activity in septic shock is due to intravascular release of group II nonpancreatic PLA2.
Similar articles
-
Pathogenesis of hypotension in septic shock: correlation of circulating phospholipase A2 levels with circulatory collapse.Crit Care Med. 1988 Jan;16(1):1-7. doi: 10.1097/00003246-198801000-00001. Crit Care Med. 1988. PMID: 3338273
-
Elevated plasma phospholipase A2 levels: correlation with the hemodynamic and pulmonary changes in gram-negative septic shock.J Lab Clin Med. 1984 Dec;104(6):873-81. J Lab Clin Med. 1984. PMID: 6548766
-
Circulating phospholipase A2 activity associated with sepsis and septic shock is indistinguishable from that associated with rheumatoid arthritis.Inflammation. 1991 Oct;15(5):355-67. doi: 10.1007/BF00917352. Inflammation. 1991. PMID: 1757123
-
Induction of group II phospholipase A2 expression and pathogenesis of the sepsis syndrome.Circ Shock. 1993 Feb;39(2):160-7. Circ Shock. 1993. PMID: 8490995 Review.
-
Serum phospholipases A2 in inflammatory diseases.Clin Chem. 1993 Dec;39(12):2453-9. Clin Chem. 1993. PMID: 8252715 Review.
Cited by
-
Phospholipase A(2) activates hemostasis.Drug Target Insights. 2007;2:83-96. Epub 2007 Mar 22. Drug Target Insights. 2007. PMID: 21901065 Free PMC article.
-
Zinc (Zn2+) binds to and stimulates the activity of group I but not group II phospholipase A2.Inflammation. 1996 Dec;20(6):599-611. doi: 10.1007/BF01488798. Inflammation. 1996. PMID: 8979149
-
Selective inhibition of group II phospholipase A2 by quercetin.Inflammation. 1993 Oct;17(5):573-82. doi: 10.1007/BF00914195. Inflammation. 1993. PMID: 8225564
-
CD64 and Group II Secretory Phospholipase A2 (sPLA2-IIA) as Biomarkers for Distinguishing Adult Sepsis and Bacterial Infections in the Emergency Department.PLoS One. 2016 Mar 22;11(3):e0152065. doi: 10.1371/journal.pone.0152065. eCollection 2016. PLoS One. 2016. PMID: 27003588 Free PMC article.
-
Effects of endotoxin and dexamethasone on group I and II phospholipase A2 in rat ileum and stomach.Gut. 1994 Jan;35(1):40-5. doi: 10.1136/gut.35.1.40. Gut. 1994. PMID: 8307447 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources